Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/9806
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site |
Author: | Parnis, F. Olver, I. Kotasek, D. Norman, J. Taylor, A. Russell, J. Patterson, K. Keefe, D. Marafioti, T. |
Citation: | Annals of Oncology, 2000; 11(7):883-884 |
Publisher: | Oxford Univ Press |
Issue Date: | 2000 |
ISSN: | 0923-7534 1569-8041 |
Statement of Responsibility: | F. X. Parnis, I. N. Olver, D. Kotasek, J. Norman, A. Taylor, J. Russell, K. Patterson, D. Keefe & T. Marafioti |
Keywords: | cisplatin epirubicin 5-fluorouracil continuous infusion unknown primary |
Rights: | © 2000 Kluwer Academic Publishers |
DOI: | 10.1023/A:1008311919633 |
Published version: | http://annonc.oxfordjournals.org/content/11/7/883.full.pdf+html |
Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.